TITLE
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [ChIP-Seq]

ORGANISM
Homo sapiens

SUMMARY
MEIS2 collaborates with AML1-ETO in inducing acute myeloid leukemia in a murine bone marrow transplantation model

DESIGN
We employed ChIP-seq to assess the impact of MEIS2 knockdown on the DNA binding profile of AML1-ETO (Kasumi-1 cell line)

PLATFORM
GPL9052 Illumina Genome Analyzer (Homo sapiens)

CITATIONS
Has this study been published? Please login to update or notify GEO .

LIBSTRATS
:CHIP-SEQ
